Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
National Cancer Center Hospital East |
Principal Investigator: |
Saori Mishima |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
National Cancer Center Hospital East Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.